BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2016 9:10:00 AM | Browse: 1205 | Download: 1445
Publication Name World Journal of Clinical Infectious Diseases
Manuscript ID 21215
Country/Territory Belgium
Received
2015-07-01 09:03
Peer-Review Started
2015-07-06 11:16
To Make the First Decision
2015-09-28 11:51
Return for Revision
2015-09-30 14:06
Revised
2015-12-02 00:00
Second Decision
2016-05-27 17:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-06-03 16:01
Articles in Press
2016-06-03 16:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-08-18 18:15
Publish the Manuscript Online
2016-08-25 09:10
ISSN 2220-3176 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Review
Article Title Clinical research in febrile neutropenia in cancer patients: Past achievements and perspectives for the future
Manuscript Source Invited Manuscript
All Author List Jean Klastersky, Marianne Paesmans, Michel Aoun, Aspasia Georgala, Angela Loizidou, Yassine Lalami and Lissandra Dal Lago
Funding Agency and Grant Number
Corresponding Author Jean Klastersky, MD, PhD, Institut Jules Bordet, Service de Médecine, Centre des Tumeurs de l’Université Libre de Bruxelles, 1, rue Héger-Bordet, 1000 Brussels, Belgium. jean.klastersky@bordet.be
Key Words Fever; Neutropenia; Prophylaxis; Algorithm; Cancer
Core Tip The overall presentation of febrile neutropenia has considerably changed over the last 50 years. Pre-vention is now feasible with the use of granulocyte colony stimulating factors. If fever appears in a neutro-penic patient, empirical therapy with broad spectrum antibiotics is mandatory; it should be adapted to the risk of severe complications that can be now predicted in individual patients using a reliable scoring system. Special situations such as persisting fever in neutropenic patients, the risk of invasive fungal infection and the management of older patients are crucial questions that are discussed as well as the issues linked to the high cost of prophylaxis and therapy.
Publish Date 2016-08-25 09:10
Citation Klastersky J, Paesmans M, Aoun M, Georgala A, Loizidou A, Lalami Y, Dal Lago L. Clinical research in febrile neutropenia in cancer patients: Past achievements and perspectives for the future. World J Clin Infect Dis 2016; 6(3): 37-60
URL http://www.wjgnet.com/2220-3176/full/v6/i3/37.htm
DOI http://dx.doi.org/10.5495/wjcid.v6.i3.37
Full Article (PDF) WJCID-6-37.pdf
Full Article (Word) WJCID-6-37.doc
Manuscript File 21215-Review.docx
Answering Reviewers 21215-Answering reviewers.pdf
Audio Core Tip 21215-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 21215-Conflict-of-interest statement.pdf
Copyright License Agreement 21215-Copyright assignment.pdf
Peer-review Report 21215-Peer-review(s).pdf
Scientific Misconduct Check 21215-Scientific misconduct check.pdf
Scientific Editor Work List 21215-Scientific editor work list.pdf